Viz AAA vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Viz.ai
VS

AI Verdict

Tool A focuses on accelerating the diagnosis and care coordination for suspected Abdominal Aortic Aneurysms using CT angiography scans. In contrast, Tool B aids in the early detection of low ejection fraction, an indicator of heart failure, by integrating AI with digital stethoscopes during routine physical exams. While both are FDA-cleared AI tools in cardiovascular health, they target different conditions and utilize distinct diagnostic modalities and clinical workflows.

Choose Viz AAA if…

Choose Viz AAA if your institution needs to rapidly identify and prioritize suspected Abdominal Aortic Aneurysm (AAA) cases directly from CT angiography scans. This tool is ideal for emergency departments, radiology, and vascular surgery teams aiming to accelerate diagnosis, streamline care coordination, and improve treatment decisions for acute aortic pathologies.

View Viz AAA →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your clinicians require a non-invasive, point-of-care screening solution for early detection of low ejection fraction during routine physical exams. This tool is best suited for primary care, internal medicine, and cardiology practices looking to quickly identify patients at risk for heart failure using integrated digital stethoscope technology.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz AAA Eko Low Ejection Fraction Tool (ELEFT)
Pricing Enterprise (hospital/health system) Unknown
Deployment Cloud-based, integrates with PACS and EHR systems. Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz AAA

Viz AAA emphasizes seamless integration into existing hospital workflows, real-time alerts, and a HIPAA-compliant communication platform for multidisciplinary teams. Its mobile access to high-fidelity imaging further enhances usability within a complex care environment, facilitating broader care coordination beyond just detection.

Clinical Value

Viz AAA

Both tools offer significant clinical value through FDA-cleared AI for critical conditions. However, Viz AAA is the 'first FDA-cleared AI-powered solution' for AAA detection and triage, directly accelerating diagnosis and care coordination for a time-sensitive, life-threatening condition. This focus on rapid intervention for acute cases gives it a slight edge in immediate critical clinical impact.

Pricing & Value

Tie

Neither tool provides public pricing tiers, making a direct comparison of value challenging. Both require direct contact for pricing information. While Viz AAA describes its subscription model based on algorithms and population size, this still lacks concrete figures to assess overall value against ELEFT's 'enterprise solution' pricing.

Enterprise Readiness

Viz AAA

Both tools are FDA-cleared, HIPAA compliant, cloud-based, and part of larger platforms, indicating strong foundational readiness. Viz AAA explicitly highlights 'integration into existing hospital workflows' and a 'HIPAA-compliant communication platform for multidisciplinary teams,' which directly addresses the complex deployment and collaborative needs of enterprise healthcare systems.

Innovation

Viz AAA

Both tools demonstrate innovation in their respective domains. Viz AAA is noted as the 'first FDA-cleared AI-powered solution' for AAA detection and triage from CT scans, marking a pioneering advancement in radiology and emergency care. While ELEFT's integration with digital stethoscopes for real-time low ejection fraction detection is also innovative, Viz AAA's 'first-in-class' status for a critical application gives it a slight lead in groundbreaking innovation.

Support & Docs

Viz AAA

Viz.ai offers a Knowledge Base, in-app support, email support, and notably, 24/7 urgent phone support with a guaranteed 15-minute callback for critical issues. This level of immediate, round-the-clock support for urgent clinical scenarios provides a stronger assurance of operational continuity compared to Eko Health's comprehensive but less explicitly urgent-focused support options.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz AAA Eko Low Ejection Fraction Tool (ELEFT)
Name Viz AAA Eko Low Ejection Fraction Tool (ELEFT)
Primary Function AI-powered detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. AI algorithm to aid clinicians in the early detection of low ejection fraction during routine physical exams.
Company Viz.ai Eko Health
Target Condition/Detection Suspected Abdominal Aortic Aneurysm (AAA) Low ejection fraction (key indicator of heart failure)
Integration/Modality From CT angiography scans, integrates into existing hospital workflows. Integrates with FDA-cleared Eko digital stethoscopes, analyzes ECG and heart sound recordings.
Specialties Emergency Medicine, Radiology, Vascular Surgery Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Viz AAA and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz AAA is designed for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. Eko Low Ejection Fraction Tool (ELEFT) aids in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Viz AAA integrates into existing hospital workflows, providing real-time alerts to care teams and a HIPAA-compliant communication platform for multidisciplinary teams. ELEFT integrates with FDA-cleared Eko digital stethoscopes, analyzing ECG and heart sound recordings to provide results in approximately 15 seconds during a physical exam.
Viz AAA utilizes CT angiography (CTA) scans for its AI-powered automatic detection of suspected AAA. ELEFT analyzes ECG and heart sound recordings, which are captured through integrated Eko digital stethoscopes.
Viz AAA is designed for specialties such as Emergency Medicine, Radiology, and Vascular Surgery. Eko Low Ejection Fraction Tool (ELEFT) is intended for Cardiology, Family Medicine, and Internal Medicine.
Viz AAA focuses on accelerating diagnosis and care coordination for suspected AAA by automatically detecting cases from CTA scans and providing real-time alerts and mobile access to imaging. ELEFT aids in the early identification of heart failure risk by non-invasively detecting low ejection fraction during routine physical exams, providing rapid AI analysis in under a minute.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.